Category: TESTIMONIALS

INTERVIEW

Psychedelic Drugs ‘Far Exceed’ Cannabis Investment Potential (CNBC)

Editor | Curator - October 19, 2021

RESEARCH

Psychedelic Therapeutics Sector Outlook Released (Valhalla Ventures)

Editor | Curator - October 18, 2021

Psychedelic Investor Guide

2021 Psychedelic Investor Guide Released.

Editor | Curator - October 18, 2021

Psychedelic Drugs ‘Far Exceed’ Cannabis Investment Potential (CNBC)

INTERVIEW Editor | Curator - October 19, 2021

Shark Tank’s Kevin O’Leary, Wesana (WSNAF) CEO Daniel Carcillo and director at Mass General Hospital’s Center for the Neuroscience of Psychedelics Dr....

Psychedelic Therapeutics Sector Outlook Released (Valhalla Ventures)

RESEARCH Editor | Curator - October 18, 2021

Valhalla Ventures backs visionary founders at the forefront of social and technological movements that younger generations care about most.

2021 Psychedelic Investor Guide Released.

Psychedelic Investor Guide Editor | Curator - October 18, 2021

Institutional Analyst Inc. announced the release of the 2021 Psychedelic Investor Guide on Monday, October 18th. The Psychedelic Investor Guide is the...